Skip to main content
Tags: Thousand Talents Plan | Harvard | Charles Lieber | espionage | grants | funding

Harvard Professor Indicted for Lying About China Funding

lieber in a black jacket standing outside speaking into a mic
Harvard University professor Charles Lieber is surrounded by reporters as he leaves the Moakley Federal Courthouse in Boston on Jan. 30, 2020. (Charles Krupa/AP Photo)

By    |   Wednesday, 10 June 2020 09:58 AM EDT

Harvard University professor Charles Lieber has been indicted on two charges of lying to government officials by a federal grand jury, Politico reports.

The chair of the Department of Chemistry and Chemical Biology at Harvard University was arrested in January and charged with making a false statement.

The allegations involved the Harvard chemist lying to government officials about his work for a Chinese university. The coronavirus postponed a hearing before a grand jury for months.

On Tuesday, a federal grand jury indicted Lieber, according to a press release from the Justice Department.

The release states that Lieber had ties with the Wuhan University of Technology while also chairing Harvard University’s Department of Chemistry. When questioned by the Department of Defense about his relationship with the Chinese school, the charging documents stated the professor lied about it. He also lied to Harvard, which caused the university to share misleading information about his affiliation with the National Institutes of Health.

Lieber denied being a participant in China’s Thousand Talents Plan. The program brings academics from across the globe to conduct research in China and work at Chinese schools. The Justice Department states that Lieber received a monthly salary of $50,000 from WUT, provided $158,000 for living expenses and given $1.5 million to establish a research lab at the Chinese campus as part of his contract through the program.

After Lieber denied his participation in the program, he received grant funding from both the DOD and NIH. Lieber’s participation in the program wasn’t the problem. He got into legal trouble when he lied about his involvement in discussions about grant funding.

U.S. security officials have raised concerns about the program’s potential to boost China’s national security because programs like the Thousand Talent’s Plan often “reward individuals for stealing proprietary information,” the Justice Department stated in a press release.

The case against Lieber is one of an overall “China Initiative” project launched by the Justice Department to combat Chinese espionage efforts in the U.S.

The project focuses on finding academics who failed to disclose Chinese government funding to the U.S. government when applying for grants.

Lieber will be sentenced at a later date. He could face up to five years in prison, three years of supervised release and a fine of $250,000, according to the Justice Department.

© 2025 Newsmax. All rights reserved.


US
Harvard University professor Charles Lieber has been indicted on two charges of lying to government officials by a federal grand jury, Politico reports. The chair of the Department of Chemistry and Chemical Biology at Harvard University was arrested in January and charged...
Thousand Talents Plan, Harvard, Charles Lieber, espionage, grants, funding
383
2020-58-10
Wednesday, 10 June 2020 09:58 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the Newsmax App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved